1. Stocker JT, Madewell JE. Persistent interstitial pulmonary emphysema: another complication of respiratory distress syndrome. Pediatrics. 1977;59:847-857.
2.
2. Heneghan MA, Sosulski R, Alarcon MB. Early pulmonary interstitial emphysema in the newborn: a grave prognostic sign. Clin Pediatr. 1987;26:361-365.
3.
3. Thibeault DW, Gregory G. Neonatal Pulmonary Care, 2nd ed.Norwalk, CT: Appleton-Century-Crofts; 1986.
4.
4. Merritt TA, Hallman M, Bloom BT, et al. Prophylactic treatment of very premature infants with human surfactant. NEngl JMed. 1986;315:785-790.
5.
5. McMillan D, Chernick V, Finer N, et al and the Canadian Exosurf Neonatal Study Group. Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1,249 grams: a double-blind, placebo-controlled, multicenter Canadian trial. J Pediatr.1995;126:s90-S98.
6.
6. Kirschner PA, Strauss L. Pulmonary interstitial emphysema in the newborn infant precursors and sequelae. Dis Chest. 1964;4:417-426.
7.
7. Miller MJ, Fanaroff AA, Martin RJ. Respiratory disorders in preterm and term infants. In: Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant, 6th ed.Baltimore: Mosby; 1997:1040-1064.
9. Robertson PA, Sniderman SH, Laros RK, et al. Neonatal morbidity according to the gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. Am J Obstet Gynecol. 1992;166:1629-1645.
10.
10. Robert MF, Neff RK, Hubbell FP, et al. Association between maternal diabetes and the respiratory-distress syndrome in the newborn. NEngl J Med. 1976;294:357-360.